insights_auto
Why is BOT down 20.00%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.0080
arrow_downward
-20.00%(-0.0020) 1D
Nov 20, 4:10:07 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
22.10M
Avg. vol.
11.07M
Volume
8.60M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
22.10M
Avg. vol.
11.07M
Volume
8.60M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Top Movers: Today's Biggest Gainers and Losers
marketscreener.com
·
13 minutes ago
S&P 500, Dow Slide Into Correction Territory as Investors Seek Treasury Cover Amid Big-Tech Plunge
Investing.com
·
37 minutes ago
S&P 500 Rebound Could Be Coming as ETF Selling Nears Capitulation
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com